is glutathione bad for heart Glutathione: Benefits and Supplements Endothelial dysfunction in cardiovascular diseases:

Efficacy of antiinflammatory treatment on major depressive disorder or depressive symptoms: metaanalysis of clinical trials

The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission

Purinergic P2X3 signaling has emerged as a promising therapeutic target for the treatment of BIPN (Holzer et al., 2022)

This phenomenon can be explained by compounds that have little to no activity, helping the main active component reach its target through mechanisms of action that complement each other, reverse resistance, improve bioavailability, reduce metabolism and excretion, and modulate side effects (93)